Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$13.67 USD
-0.12 (-0.87%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $13.67 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Dr. Reddy's Laboratories Ltd has a market cap of $11.51B, which represents its share price of $13.79 multiplied by its outstanding shares number of 834.90M. As a large-cap company, RDY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RDY 13.67 -0.12(-0.87%)
Will RDY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RDY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RDY
Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues
RDY: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for July 18th
Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?
Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
Other News for RDY
Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues
SA Asks: Which stocks could be impacted by higher India tariffs?
Dr Reddy's Laboratories Ltd (RDY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
Wall Street Lunch: Return Of Meme Stock Frenzy Causes Volatility In The Market
Q1 2026 Dr Reddy's Laboratories Ltd Earnings Call Transcript